G

Genomictree Inc
KOSDAQ:228760

Watchlist Manager
Genomictree Inc
KOSDAQ:228760
Watchlist
Price: 22 350 KRW -1.97% Market Closed
Market Cap: 544.9B KRW

Operating Margin

-328.3%
Current
Improving
by 113.1%
vs 3-y average of -441.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-328.3%
=
Operating Income
₩-12.3B
/
Revenue
₩3.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-328.3%
=
Operating Income
₩-12.3B
/
Revenue
₩3.8B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Genomictree Inc
KOSDAQ:228760
536.8B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
380.6B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
182.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
158.6B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.7B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.5B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...
No Stocks Found

Market Distribution

Lower than 97% of companies in Korea
Percentile
3nd
Based on 2 615 companies
3nd percentile
-328.3%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Genomictree Inc
Glance View

Market Cap
544.9B KRW
Industry
Biotechnology

Genomictree, Inc. engages in the development and supply of diagnostic products for cancer screening and prognosis. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2016-07-19. The firm is involved in conducting of genomic analysis using microarrays and next generation sequencing analysis. In addition, the Company is conducting clinical trials for molecular diagnostic products. Molecular diagnostic products include cancer molecular diagnostic products and molecular genetic diagnostic products. Cancer molecular diagnostic products include molecular diagnostic products for colorectal cancer, bladder cancer, lung cancer, stomach cancer, cervical cancer. Molecular genetic diagnostic products include epidermal growth factor receptor (EGFR) mutation diagnosis, as well as human papilloma virus (HPV) diagnostic products.

Genomictree Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-328.3%
=
Operating Income
₩-12.3B
/
Revenue
₩3.8B
What is Genomictree Inc's current Operating Margin?

The current Operating Margin for Genomictree Inc is -328.3%, which is above its 3-year median of -441.3%.

How has Operating Margin changed over time?

Over the last 3 years, Genomictree Inc’s Operating Margin has decreased from 18.7% to -328.3%. During this period, it reached a low of -706% on Jun 30, 2024 and a high of 18.7% on Aug 30, 2022.

Back to Top